SKI Market

A+| A| A-|

Indian Indices

Sensex

77,562.90 2,946.32
( 3.95%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,352.49 -83.80
(-0.80%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

60.36

155281.86

EPS(TTM)

Face Value()

Div & Yield %

96.91

0.51

Back

sarvottan finvest ltd

Balgopal Commercial reports consolidated net profit of Rs 0.75 crore in the December 2025 quarter

Feb 13,2026

Net profit of Balgopal Commercial reported to Rs 0.75 crore in the quarter ended December 2025 as against net loss of Rs 0.46 crore during the previous quarter ended December 2024. Sales declined 88.89% to Rs 0.02 crore in the quarter ended December 2025 as against Rs 0.18 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.02	0.18	-89
OPM %	-1900.00	-255.56	-
PBDT	0.59	-0.29	LP
PBT	0.59	-0.29	LP
NP	0.75	-0.46	LP

77,562.90 2,946.32 ( 3.95%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,352.49 -83.80 (-0.80%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)